Table 1.
Plurinet, % | Oct4/Sox2/Nanog, % | Nanog, % | Oct4, % | Sox2, % | Glioblastoma, % | Huntington's disease, % | REST-miRNA network, % | |
(225) | (408) | (4,085) | (3,309) | (1,113) | (192) | (37) | (16) | |
CoREST (1,820) | 22 (49)** | 19 (79)* | 16 (671)* | 17 (574)* | 19 (208)* | 15 (29)* | 19 (7) | 19 (3) |
REST (322) | 2 (4) | 2 (8) | 2 (88) | 3 (86)* | 2 (25) | 2 (3) | 22 (8)* | 0 (0) |
Shown are genes involved in pluripotency, including “Plurinet” (23) and composite and individual Oct4/Sox2/Nanog networks (24), neurological diseases (glioblastoma, ref. 25; and Huntington's, ref. 27), and REST-miRNA networks (28). Percentage refers to the proportion of genes within a particular network that are CoREST or REST NSC targets, and the numbers in parentheses represent the actual number of genes.
*P < 0.001.